ArticleHeliyon2024

Pharmaceutical inhibition of BCL6 ameliorates resistance to imatinib in chronic myeloid leukemia.

Yingying Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.